In HCC tumors with high OX40 expression, despite the greater activation of Teffs, they do not correlate to increased antitumor activities, suggesting the involvement of functionally defective CD8+ T cells or immune checkpoint molecules (Xie et al., 2018). Here, TNFRSF4 is linked to hepatocellular carcinoma.